Abstract

The JAOA and the author regret errors that appeared in the following supplement article: Barag SH. Insulin therapy for management of type 2 diabetes mellitus: strategies for initiation and longterm patient adherence. J Am Osteopath Assoc. 2011; 111(7 suppl 5):S13-S16. In Figure 3, the second and third mean fasting plasma glucose levels were incorrectly reported as 80-100 mg/dL and >100 mg/dL, respectively. They should have been reported as 80-110 mg/dL and >110 mg/dL. In addition, the JAOA and the author regret errors that appeared in the following supplement article: Garber AJ. Novel incretin-based agents and practical regimens to meet needs and treatment goals of patients with type 2 diabetes mellitus.J Am Osteopath Assoc. 2011;111(7 suppl 5):S20-S30. In Figure 3,references for and information regarding the agent liraglutide was incorrect. The references cited should have included references 35 to 40, the change in HbA1c level should have been reported as -0.6% to -1.5% (not 1.4% to 1.9%), the change in body weight should have appeared as -1.0 to -3.2 kg (not 3.7 to 3.8 kg), and the change in systolic blood pressure should have been reported as -0.6 to -7.9 mm Hg (not 4.7 mm Hg). In addition, in the second column on page S24, the reference to Figure 2 should have been to Figure 3. These changes will be made to both the full text and PDF versions of the article online.

Read Full Article